US FDA creates new task force and “blog” to increase transparency
This article was originally published in SRA
The US Food and Drug Administration, in order to increase transparency around its decision-making process, has established a task force that will look at ways to provide the public with useful and understandable information about the agency’s activities in a more timely and user-friendly format1.
You may also be interested in...
Device companies operating in Canada are being advised to review their internal procedures in anticipation of new postmarket requirements that come into force this year.
Remote inspections are here to stay, and global regulators are aligning efforts to develop consensus on how these should be conducted.
The Canadian medtech regulator has recommended updating its list of recognized medical device standards that manufacturers can rely on to demonstrate compliance with local safety, effectiveness and labeling requirements.